News
The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight management. Signos integrates the Stelo by Dexcom ...
The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, including weight management support. The device offers real-time glucose tracking ...
You've probably heard that protein is queen when it comes to keeping you full and satisfied all day. But it doesn't get the job completely done without the help of its trusty sidekick macronutrients: ...
GLP-1 drugs don't work equally well for everyone, but there are some changes that can help you optimize your weight loss. GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro ...
TAMPA, Fla. (WFLA) — Florida Surgeon General Dr. Joseph Ladapo announced a new state-funded weight management program for residents in three Florida counties on Thursday. The program will provide ...
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care. Their qualitative study, "Understanding ...
The success of GLP-1 medications has made drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) seem like a magic bullet for weight loss. But using these injectable drugs doesn ...
Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...
Beyond diabetes control and weight management, GLP-1s could have yet another benefit: helping with migraines. In a small study, a GLP-1 drug shrank the number of days people spent with a migraine by ...
David Kessler took GLP-1 drugs to help manage his weight. In his new book, he explains why the drugs are revolutionary, but not a panacea. The following is an excerpt from Diet, Drugs, and Dopamine: ...
SUZHOU, China, June 23, 2025 /PRNewswire/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results